Sg Americas Securities, LLC Beyond Spring Inc. Transaction History

Sg Americas Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$0.85 - $3.63 $14,908 - $63,666	17,539 New	17,539 $63,000
Q4 2021 Feb 07, 2022	SELL	$4.02 - $16.84 $40,714 - $170,555	-10,128 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$9.26 - $31.31 $93,785 - $317,107	10,128 New	10,128 $160,000
Q3 2020 Nov 09, 2020	SELL	$9.99 - $16.13 $73,906 - $119,329	-7,398 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$11.21 - $18.15 $82,931 - $134,273	7,398 New	7,398 $112,000

5.77M

53.2K

2.5K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $81.8M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.